Prosetta Biosciences
PrivateLast Round
Series D
Dec 3, 2015
Est. Valuation
$20M
Total Funding Raised
$41.58M
Company Overview
Prosetta Biosciences is a biotechnology company that develops small-molecule antiviral therapeutics and advances drug discovery for oncology, neurodegenerative diseases, and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Prosetta Biosciences Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Prosetta Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Dec 3, 2015 | ||||
| Series B | Jul 19, 2012 | ||||
| Grant | Jun 8, 2012 | ||||
| Series A | May 18, 2007 |
Key People
Founding team and executive leadership
Prosetta Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| Alger | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 8, 2012
$442K grant from U.S. Department of Health and Human Services
Prosetta Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Prosetta Biosciences's valuation, stock price, and market status.